Shire/Noven Daytrana Patch To Carry Similar Warnings To Other ADHD Drugs, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The transdermal methylphenidate patch is approved with one additional warning relating to skin reactions and possible sensitivity to oral methylphenidate products.